BONNIE S GLISSON to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications BONNIE S GLISSON has written about TOR Serine-Threonine Kinases.
Connection Strength
0.101
-
Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48.
Score: 0.060
-
PI3-kinase pathway biomarkers in oral cancer and tumor immune cells. Head Neck. 2019 03; 41(3):615-622.
Score: 0.025
-
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2012 Sep; 2(9):798-811.
Score: 0.016